Innospera Pharma Inc.
PrivateLast Round
Seed
May 5, 2025
Total Funding Raised
$5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Innospera Pharma Inc. operates in Healthcare & Life Sciences and is based in Montreal. Its latest recorded funding round was a Seed round in May 2025.
Innospera Pharma Inc. is a biotechnology company that develops small-molecule GPCR modulators for chronic inflammatory, metabolic, and fibrotic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Innospera Pharma Inc. Comparables
Compare Innospera Pharma Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Liminal BioSciences Inc. | 83% | |
| Galapagos NV | 74% | |
| Structure Therapeutics | 74% |
For institutional investors. Book with your work email.
Innospera Pharma Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Innospera Pharma Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investissement Québec | Seed |
| Bastien Family Office | Seed |
| Investissement Québec | Seed |
| Anges Quebec | Seed |
| Seido Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 70% MoM.
- May 15, 2026
Monthly visitors increased 155% MoM.
For institutional investors. Book with your work email.
Innospera Pharma Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Innospera Pharma Inc.'s valuation, stock price, and market status.
Is Innospera Pharma Inc. a public or private company?
Innospera Pharma Inc. is a private company.
What is the current stock price of Innospera Pharma Inc.?
Innospera Pharma Inc. is a private company, so its shares have no public market price. Caplight tracks Innospera Pharma Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Innospera Pharma Inc. worth (valuation)?
Valuation information for Innospera Pharma Inc. is not publicly available.
Can I buy Innospera Pharma Inc. stock?
Innospera Pharma Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Innospera Pharma Inc.'s last funding round?
Innospera Pharma Inc.'s most recent funding round was Seed on May 5, 2025.
Who are the main investors in Innospera Pharma Inc.?
Key investors in Innospera Pharma Inc. include Investissement Québec, Bastien Family Office, Investissement Québec, Anges Quebec, Seido Capital.
Will Innospera Pharma Inc. IPO soon?
No public IPO plans have been announced for Innospera Pharma Inc..
How can I track Innospera Pharma Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Innospera Pharma Inc.'s shares on secondary markets.